USANA Health ( (USNA) ) has shared an announcement.
USANA Health Sciences reported a decline in financial performance for the fiscal year 2024, with net sales dropping to $855 million from $921 million in 2023, and net earnings falling to $42 million from $63.8 million. The company’s acquisition of Hiya Health Products, completed in December 2024, is expected to bolster its market position in the children’s health segment, although Hiya’s contribution to the year’s financial results was minimal. Despite challenges in the Asia Pacific market, USANA saw growth in the Americas and Europe, and the company remains optimistic about its growth strategy for 2025, projecting net sales between $920 million and $1 billion.
More about USANA Health
USANA Health Sciences, Inc. operates in the health and wellness industry, focusing primarily on nutritional products and supplements. The company has a significant market presence in the Asia Pacific region, as well as in the Americas and Europe, and recently expanded its portfolio by acquiring a controlling stake in Hiya Health Products, a direct-to-consumer children’s wellness brand.
YTD Price Performance: -10.17%
Average Trading Volume: 128,722
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $623.1M
See more insights into USNA stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com